ilShinbiobase일신바이오
068330 · KOSDAQ · ₩068330 · 일신바이오
₩1,009▲ ₩4 (0.40%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 54.0% | 53.1% | 58.0% | 57.4% | 51.4% | 51.9% |
| Operating margin | 31.4% | 31.3% | 20.9% | 37.8% | 25.2% | 30.1% |
| Net margin | 38.1% | 33.0% | 35.2% | 37.9% | 18.7% | 24.0% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +8.7% | +34.3% | −34.2% | −19.6% | −16.2% | — |
| Operating income growth | +9.2% | +101.0% | −63.6% | +20.9% | −29.9% | — |
| Net income growth | +25.4% | +25.8% | −38.8% | +63.4% | −34.9% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 9.1% | 7.7% | 6.5% | 11.2% | 7.3% | 11.7% |
| Return on assets | 8.4% | 7.2% | 6.1% | 10.5% | 6.6% | 10.4% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 10.0% | 5.8% | 5.8% | 6.2% | 8.6% | 12.7% |
| Net debt to equity | — | — | — | — | −7.8% | −18.9% |
| Current ratio | 926.5% | 1,482.0% | 1,441.7% | 1,350.8% | 930.6% | 641.5% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: ilShinbiobase / 일신바이오 / 068330 / KRX:068330
Source: KRX statistical information